Richard E Lowenthal

CIK 1378550 · PRESIDENT AND CEO · last filed 2026-01-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$74.77M

Companies

2

Total Filings

37

Lifetime Open-Market Net

-$23.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SPRY PRESIDENT AND CEO 13,186,389 $5.67 $74.77M -$23.82M 31 2026-01-05
CADENCE PHARMACEUTICALS INC (CADX) Delisted VP $0 1 2007-03-26

Recent Filings · Page 4 of 4

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-03-01 SPRY Sell (S) −3,782 -$34.1K EDGAR
2024-02-28 SPRY Sell (S) −99,478 -$897.4K EDGAR
2024-02-26 SPRY Notice (144) −400,000 -$3.60M EDGAR
2024-01-04 SPRY Mixed $0 EDGAR
2023-01-05 SPRY Grant (A) $0 EDGAR
2022-11-10 SPRY Grant (A) +13,049,376 $0 EDGAR
2007-03-26 CADENCE PHARMACEUTICALS INC (CADX) Delisted Grant (A) $0 EDGAR
Showing 3137 of 37
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.